Tolerance to the procholinergic action of the D1 receptor full agonist dihydrexidine

被引：0
|
作者：
Mark R. Wade
George G. Nomikos
机构：
[1] Eli Lilly and Company,Neuroscience Discovery Research
[2] Lilly Corporate Center,undefined
来源：
Psychopharmacology | 2005年 / 182卷
关键词：
Acetylcholine release; Cognition; D1; Dementia; Dopamine receptor; Hippocampus; In vivo microdialysis; Tolerance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：393 / 399
页数：6
相关论文
共 50 条
  • [31] Aberrant behavioral effects of a dopamine D1 receptor antagonist and agonist in monkeys: Evidence of uncharted dopamine D1 receptor actions
    Peacock, L
    Gerlach, J
    BIOLOGICAL PSYCHIATRY, 2001, 50 (07) : 501 - 509
  • [32] D1 AND D2 DOPAMINE AGONIST SYNERGISM - SEPARATE SITES OF ACTION
    ROBERTSON, GS
    ROBERTSON, HA
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1987, 8 (08) : 295 - 299
  • [33] A68930 - A POTENT AGONIST SPECIFIC FOR THE DOPAMINE D1 RECEPTOR
    KEBABIAN, JW
    DENINNO, MP
    SCHOENLEBER, R
    MACKENZIE, R
    BRITTON, DR
    ASIN, KE
    NEUROCHEMISTRY INTERNATIONAL, 1992, 20 : S157 - S160
  • [34] A D1/D2 CHIMERIC DOPAMINE RECEPTOR MEDIATES A D1 RESPONSE TO A D2-SELECTIVE AGONIST
    MACKENZIE, RG
    STEFFEY, ME
    MANELLI, AM
    POLLOCK, NJ
    FRAIL, DE
    FEBS LETTERS, 1993, 323 (1-2) : 59 - 62
  • [35] Comparison of the D1 dopamine full agonists, dihydrexidine and doxanthrine, in the 6-OHDA rat model of Parkinson's disease
    McCorvy, John D.
    Watts, Val J.
    Nichols, David E.
    PSYCHOPHARMACOLOGY, 2012, 222 (01) : 81 - 87
  • [36] Comparison of the enantiomers of (±)-doxanthrine, a high efficacy full dopamine D1 receptor agonist, and a reversal of enantioselectivity at D1 versus alpha2C adrenergic receptors
    Przybyla, Julie A.
    Cueva, Juan P.
    Chemel, Benjamin R.
    Hsu, K. Joseph
    Riese, David J., II
    McCorvy, John D.
    Chester, Julia A.
    Nichols, David E.
    Watts, Val J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 (02) : 138 - 146
  • [37] The D-1 agonist dihydrexidine releases acetylcholine and improves cognition in rats
    Steele, TD
    Hodges, DB
    Levesque, TR
    Locke, KW
    Sandage, BW
    NEUROBIOLOGY OF ALZHEIMER'S DISEASE, 1996, 777 : 427 - 430
  • [38] Comparison of the D1 dopamine full agonists, dihydrexidine and doxanthrine, in the 6-OHDA rat model of Parkinson's disease
    John D. McCorvy
    Val J. Watts
    David E. Nichols
    Psychopharmacology, 2012, 222 : 81 - 87
  • [39] The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors
    Andringa, G
    Drukarch, B
    Leysen, JE
    Cools, AR
    Stoof, JC
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 364 (01) : 33 - 41
  • [40] EFFECTS OF CLOZAPINE ON BEHAVIORAL-RESPONSES TO THE NEW SELECTIVE D1 DOPAMINE RECEPTOR AGONIST A 68930 - INVOLVEMENT OF A D1 RECEPTOR SUBTYPE
    DALY, SA
    WADDINGTON, JL
    BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 : P65 - P65
12345